IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT05971394
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT05971394
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT05971394. Allocation not applicable; no masking; primary purpose treatment. Start 2023-07-17 (actual); primary completion 2026-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial
- Condition
- Infrapopliteal Lesions
- Condition
- Critical Limb Ischemia
- Intervention (Device)
- Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
- Lead sponsor
- Biotyx Medical (Shenzhen) Co., Ltd.
- Collaborator
- VascuScience GmbH
- Collaborator
- Mediolanum Cardio Research
- Collaborator
- Euroimage Research Srl
Record details
- Record id
cardio:ct-nct05971394- Content hash
75578028f71e1180a06449163b674dd7cba66a374da67d1d5b912afa2156be90